Ex-Aegerion Rep. Strikes Deal To Avoid 2nd Fraud Trial

By Chris Villani · November 13, 2023, 1:42 PM EST

A former Aegerion Pharmaceuticals sales representative will plead guilty to his involvement in a scheme to fraudulently sell the company's cholesterol treatment, forgoing a second trial and ending a long-running case...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Plea Agreement

Case Information

Case Title

Case Number

Court

Massachusetts

Nature of Suit

Date Filed

August 07, 2018

Recent Articles By Chris

March 01, 2024
GSK, Shook Hardy Can Recover Costs After Zofran MDL Win
February 26, 2024
Teva Tells 1st Circ. Feds Must Clear High Bar In FCA Case
February 20, 2024
Justices Decline Malpractice Dispute Over $6M Settlement
December 21, 2023
The 5 Biggest First Circuit Rulings Of 2023
December 20, 2023
No Discovery In Regeneron FCA Case Until 1st Circ. Rules
November 21, 2023
Ex-Aegerion Rep Cops To Fraud, Avoiding Trial Redo
November 13, 2023
Florida Duo Cops To $1.5M Medicare Fraud In Ga. Court
November 02, 2023
Firms Ask 1st Circ. To Force Ruling In Fee Row After 5 Years
October 05, 2023
1st Circ. Unsure Zurich Is On Safe Ground In Flood Limit Suits
October 04, 2023
Vax Refusal Shouldn't Negate Benefits, Mass. Justices Hint